Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Idoko Ja"'
Autor:
Anejo-Okopi, JA, Agbaji, OO, Agaba, PA, Ugoagwu, PO, Were, K, Onywera, H, Owiti, P, Isa, SE, Otecko, N, Okwori, AEJ, Musa, J, Oguche, S, Sagay, AS, Idoko, JA, Nimzing, L, Jatau, ED, Olonitola, OS
Publikováno v:
African Journal of Biotechnology; Vol 12, No 17 (2013)
The presence of human immunodeficiency virus (HIV) type-1 diversity has an impact on vaccine efficacy and drug resistance. It is important to know the circulating genetic variants and associated drug-resistance mutations in the context of scale up of
Publikováno v:
Nigerian Journal of Parasitology; Vol 32, No 2 (2011)
A total of 234 male prisoners from Jos Prison had their blood samples collected and screened for antibodies against Human Immunodeficiency Virus (HIV) types I and II using Determine and Stat-pak. The objective of this study was to determine the preva
Publikováno v:
Nigerian Journal of Medicine; Vol 21, No 2 (2012); 209-213
No Abstract.
Publikováno v:
Nigerian Journal of Medicine; Vol 17, No 1 (2008); 83-87
Background: The clinical characteristics and consequences of HIV-1 infection observed in studies from developed countries cannot be generalized across the multiple virus subtypes that circulate in sub-Saharan Africa in general and Nigeria in particul
Autor:
Agaba, PA, Meloni, ST, Sule, HM, Agbaji, OO, Ekeh, PN, Job, GC, Nyango, N, Ugoagwu, PO, Imade, GE, Idoko, JA, Kanki, PJ
Publikováno v:
HIV Medicine; Aug2014, Vol. 15 Issue 7, p396-405, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Idoko JA; Department of Medicine, Infectious Diseases Unit, University of Jos, Jos, Nigeria. jonidoko@yahoo.com.; Federal University of Health Sciences, Otukpo, Nigeria. jonidoko@yahoo.com., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-FIOCRUZ, Rio de Janeiro, Brazil. gbeatriz@ini.fiocruz.br., Phanuphak N; Institute of HIV Research and Innovation, Bangkok, Thailand. nittaya.p@ihri.org.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2022 Dec 12; Vol. 2 (1), pp. 161. Date of Electronic Publication: 2022 Dec 12.
Autor:
Agbaji OO; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria.; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria., Abah IO; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 3 Pharmacy Department, Jos University Teaching Hospital, Jos, Nigeria., Ebonyi AO; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 4 Department of Paediatrics, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Gimba ZM; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Abene EE; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Gomerep SS; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria.; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria., Falang KD; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 5 Department of Pharmacology, University of Jos, Jos, Nigeria., Anejo-Okopi J; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 6 Department of Microbiology, University of Jos, Jos, Nigeria., Agaba PA; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 7 Department of Family Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Ugoagwu PO; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria., Agaba EI; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Imade GE; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 8 Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Sagay AS; 2 APIN-supported HIV Treatment Centre, Jos University Teaching Hospital, Jos, Nigeria.; 8 Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Okonkwo P; 9 APIN Public Health Initiatives, Ltd/Gte, Abuja, Nigeria., Idoko JA; 1 Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Kanki PJ; 10 Department of Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Publikováno v:
Journal of the International Association of Providers of AIDS Care [J Int Assoc Provid AIDS Care] 2019 Jan-Dec; Vol. 18, pp. 2325958218821963.